Pricing
Login
Home
Charts
Search
Watchlist
Products

Sai Parenterals Ltd

SAIPARENT
₹492.30-0.63%20 Nov 2026
Reports
Pharma Formulations

Sai Parenterals Ltd

SAIPARENT
₹492.30
-0.63%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹2,175Cr
Close
Close Price
₹492.30
Industry
Industry
Pharma Formulations
PE
Price To Earnings
82.46
PS
Price To Sales
3.26
Revenue
Revenue
₹668Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
—

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterJun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
335496198179195
Growth YoY
Revenue Growth YoY%
435.1264.1
Expenses
ExpensesCr
2942100172155155
Operating Profit
Operating ProfitCr
511-4262440
OPM
OPM%
14.221.4-3.713.213.220.6
Other Income
Other IncomeCr
113344
Interest Expense
Interest ExpenseCr
225899
Depreciation
DepreciationCr
1168825
PBT
PBTCr
29-12121010
Tax
TaxCr
13-5-12-1
PAT
PATCr
16-713811
Growth YoY
PAT Growth YoY%
457.865.5
NPM
NPM%
4.311.9-6.96.74.45.4
EPS
EPS₹
0.134.4-2.24.01.82.4
QuarterJun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
335496198179195
Growth YoY
Revenue Growth YoY%
435.1264.1
Expenses
ExpensesCr
2942100172155155
Operating Profit
Operating ProfitCr
511-4262440
OPM
OPM%
14.221.4-3.713.213.220.6
Other Income
Other IncomeCr
113344
Interest Expense
Interest ExpenseCr
225899
Depreciation
DepreciationCr
1168825
PBT
PBTCr
29-12121010
Tax
TaxCr
13-5-12-1
PAT
PATCr
16-713811
Growth YoY
PAT Growth YoY%
457.865.5
NPM
NPM%
4.311.9-6.96.74.45.4
EPS
EPS₹
0.134.4-2.24.01.82.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
97154163381668
Growth
Revenue Growth%
58.96.1133.6
Expenses
ExpensesCr
79122124342581
Operating Profit
Operating ProfitCr
1832393986
OPM
OPM%
18.220.624.110.212.9
Other Income
Other IncomeCr
011913
Interest Expense
Interest ExpenseCr
511121832
Depreciation
DepreciationCr
6981747
PBT
PBTCr
713201220
Tax
TaxCr
345-2-4
PAT
PATCr
48141425
Growth
PAT Growth%
92.371.4-1.2
NPM
NPM%
4.55.58.83.73.7
EPS
EPS₹
6.210.55.44.46.0
Financial YearMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
97154163381668
Growth
Revenue Growth%
58.96.1133.6
Expenses
ExpensesCr
79122124342581
Operating Profit
Operating ProfitCr
1832393986
OPM
OPM%
18.220.624.110.212.9
Other Income
Other IncomeCr
011913
Interest Expense
Interest ExpenseCr
511121832
Depreciation
DepreciationCr
6981747
PBT
PBTCr
713201220
Tax
TaxCr
345-2-4
PAT
PATCr
48141425
Growth
PAT Growth%
92.371.4-1.2
NPM
NPM%
4.55.58.83.73.7
EPS
EPS₹
6.210.55.44.46.0
Sales CAGR
1 Year134%
3 Years58%
5 Years-
TTM-
EBITDA CAGR
1 Year-2%
3 Years30%
5 Years-
TTM-
PAT CAGR
1 Year-1%
3 Years48%
5 Years-
TTM-
Avg. ROCE
1 Year3%
3 Years11%
5 Years-
TTM6%
CFO / EBITDA
1 Year240%
3 Years88%
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
7131322312
Reserves
ReservesCr
246180469184
Current Liabilities
Current LiabilitiesCr
77153162573464
Non Current Liabilities
Non Current LiabilitiesCr
263914356348
Total Liabilities
Total LiabilitiesCr
1342682721,4241,320
Current Assets
Current AssetsCr
82187200822635
Non Current Assets
Non Current AssetsCr
528172602685
Total Assets
Total AssetsCr
1342682721,4241,320
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
7131322312
Reserves
ReservesCr
246180469184
Current Liabilities
Current LiabilitiesCr
77153162573464
Non Current Liabilities
Non Current LiabilitiesCr
263914356348
Total Liabilities
Total LiabilitiesCr
1342682721,4241,320
Current Assets
Current AssetsCr
82187200822635
Non Current Assets
Non Current AssetsCr
528172602685
Total Assets
Total AssetsCr
1342682721,4241,320

Cash Flow

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-13-303393
Investing Cash Flow
Investing Cash FlowCr
-19-460-274
Financing Cash Flow
Financing Cash FlowCr
2479-36596
Net Cash Flow
Net Cash FlowCr
-82-2415
Free Cash Flow
Free Cash FlowCr
-29-654275
CFO To PAT
CFO To PAT%
-292.5-353.7229.8652.6
CFO To EBITDA
CFO To EBITDA%
-72.6-94.084.2240.4
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-13-303393
Investing Cash Flow
Investing Cash FlowCr
-19-460-274
Financing Cash Flow
Financing Cash FlowCr
2479-36596
Net Cash Flow
Net Cash FlowCr
-82-2415
Free Cash Flow
Free Cash FlowCr
-29-654275
CFO To PAT
CFO To PAT%
-292.5-353.7229.8652.6
CFO To EBITDA
CFO To EBITDA%
-72.6-94.084.2240.4

Ratios

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,175
Price To Earnings
Price To Earnings
82.5
Price To Sales
Price To Sales
3.3
Price To Book
Price To Book
10.6
EV To EBITDA
EV To EBITDA
28.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.035.339.334.834.8
OPM
OPM%
18.220.624.110.212.9
NPM
NPM%
4.55.58.83.73.7
ROCE
ROCE%
12.112.217.03.26.2
ROE
ROE%
13.911.315.42.95.0
ROA
ROA%
3.33.15.31.01.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,175
Price To Earnings
Price To Earnings
82.5
Price To Sales
Price To Sales
3.3
Price To Book
Price To Book
10.6
EV To EBITDA
EV To EBITDA
28.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.035.339.334.834.8
OPM
OPM%
18.220.624.110.212.9
NPM
NPM%
4.55.58.83.73.7
ROCE
ROCE%
12.112.217.03.26.2
ROE
ROE%
13.911.315.42.95.0
ROA
ROA%
3.33.15.31.01.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr4,1942,9012,7572,1752,1431,8411,593
Close PriceClose₹418.251,693.90317.05492.30232.151,655.402,312.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE52.4151.4932.4882.4667.6833.99
Price To SalesPS4.063.343.663.261.124.144.04
RevenueRevenueCr1,0328707536681,909444395
Revenue Growth TTMRev Gr TTM%18.2%30.1%10.6%15.2%10.6%
PAT Growth TTMPAT Gr TTM%40.7%-64.3%127.6%27.3%64.3%
Market CapitalizationMkt CapCr4,1942,9012,7572,1752,1431,8411,593
Close PriceClose₹418.251,693.90317.05492.30232.151,655.402,312.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE52.4151.4932.4882.4667.6833.99
Price To SalesPS4.063.343.663.261.124.144.04
RevenueRevenueCr1,0328707536681,909444395
Revenue Growth TTMRev Gr TTM%18.2%30.1%10.6%15.2%10.6%
PAT Growth TTMPAT Gr TTM%40.7%-64.3%127.6%27.3%64.3%
Annual Reports
FY2026
Quarterly Reports
FY2026
Annual Reports
Quarterly Reports
Load More
Interviews